<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04566575</url>
  </required_header>
  <id_info>
    <org_study_id>2020-01874; sp20Fellmann</org_study_id>
    <nct_id>NCT04566575</nct_id>
  </id_info>
  <brief_title>Isthmocele - Prediction, Prevention, Diagnosis, and Management</brief_title>
  <official_title>Isthmocele - Prediction, Prevention, Diagnosis, and Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An Isthmocele is a scar defect or uterine niche that develops in the myometrium due to an&#xD;
      inadequate healing process at the site of the caesarean section incision. The management of&#xD;
      isthmocele is not standardized and a correction typically involves invasive procedures&#xD;
      (hysteroscopy/resectoscopy, laparoscopy, vaginal surgery). This study is to investigate the&#xD;
      effectiveness of the procedures used to treat isthmocele.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 30, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Myometrium thickness after isthmocele correction procedure (mm)</measure>
    <time_frame>single time-point at baseline (approx. 10 minutes)</time_frame>
    <description>Myometrium thickness after isthmocele correction procedure (mm), compared to myometrium thickness before isthmocele correction procedure, measured by TVUS (in mm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of new cysts in the area of caesarean sectio after isthmocele correction procedure</measure>
    <time_frame>single time-point at baseline (approx. 10 minutes)</time_frame>
    <description>Occurrence of new cysts in the area of caesarean sectio after isthmocele correction procedure, measured by TVUS and compared to number of cysts before isthmocele correction procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient satisfaction after isthmocele correction procedure</measure>
    <time_frame>single time-point at baseline (approx. 10 minutes)</time_frame>
    <description>Patient satisfaction after isthmocele correction procedure, analysed by explorative questionnaire ( ranging from a = very satisfied to f = absolutely not satisfied)</description>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Isthmocele</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>trans vaginal ultrasound (TVUS)</intervention_name>
    <description>In the TVUS, the residual myometrium is determined after surgery and the appearance of new cysts in the area of the caesarian section scar is assessed.</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>patient questionnaire</intervention_name>
    <description>exploratory patient questionnaire regarding satisfaction after correction of isthmocele</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent surgery for isthmocele at the University Hospital Basel between&#xD;
        01.01.2017 and 31.12.2020. Time interval from the operation performed to the study-specific&#xD;
        consultation has a maximum of 4 years.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing isthmocele correction surgery within the period from 01.01.2017 to&#xD;
             31.12.2020 at the University Hospital Basel, Women's Hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Missing information on the preoperative initial situation (preoperative myometrium&#xD;
             thickness, lack of imaging via TVUS)&#xD;
&#xD;
          -  Missing information on key characteristics that are important in the collection of&#xD;
             retrospective data analysis (e.g. data on the previous caesarean section)&#xD;
&#xD;
          -  Inability to give an informed consent&#xD;
&#xD;
          -  Lack of German language skills&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Viola Heinzelmann, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Basel, Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Basel, Women's Hospital</name>
      <address>
        <city>Basel</city>
        <zip>4056</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>September 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>December 18, 2020</last_update_submitted>
  <last_update_submitted_qc>December 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Caesarean section</keyword>
  <keyword>Myometrium</keyword>
  <keyword>Hydrometra</keyword>
  <keyword>transvaginal ultrasound</keyword>
  <keyword>Isthmocele correction</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

